You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Water Purification using TiO2 and Novel Activation Method
SBC: Imaging Systems Technology, Inc. Topic: AUnder this Phase II SBIR, Imaging Systems Technology (IST) will optimize and scale up its UV Plasma- shells with Titanium (IV) Dioxide (TiO2) system to produce a low cost, rugged, lightweight, and highly efficient and versatile water purification system. Plasma-shells are tiny hollow gas encapsulating devices ranging in size from 400 microns to 8.00 mm. Under the EPA Phase I SBIR, IST has successf ...
SBIR Phase II 2014 Environmental Protection Agency -
Development of Zinc Coatings on Steel by Cermaclad(TM) to Replace Pickling Lines
SBC: MesoCoat Topic: BEvery year, a significant amount of money is lost due to atmospheric attack of steel parts. A convenient and effective way for corrosion protection is coating the unalloyed steel with a thin layer of zinc (Zn) metal by galvanizing. Pickling is an essential step of this process to ensure a high-quality surface of steel for further processing. In this process, acid is used to remove scale from the s ...
SBIR Phase I 2014 Environmental Protection Agency -
Phosphorus Removal and Recovery From Municipal Wastewater Using Nano-Enhanced Media
SBC: MetaMateria Technologies, LLC Topic: AThis Small Business Innovation Research (SBIR) Phase I project will develop approaches for the capture and recovery of phosphorus in municipal reclamation facilities processing under I MGD using an innovative nanostructured sorption media. The captured phosphorous will be recovered from the media by a simple treatment and will be converted to a useful material.Eutrophication is a process in which ...
SBIR Phase I 2014 Environmental Protection Agency -
Clear Cues: Supportive Wayfinding for Care Communities
SBC: Linda-&-Cameron, Inc. Topic: NIADESCRIPTION (provided by applicant): The purpose of this project is to develop and test Clear Cues (CC), a signage system for care communities that supports way finding in people with dementia. Way finding is a process through which people use informationin the environment to help them get to their desired destination. It's both the user experience of choosing a path and the design elements t ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Novel Alzheimer's Disease Drug Treatment
SBC: P2D, INC Topic: NIADESCRIPTION (provided by applicant): P2D Bioscience is developing the selective, non-addicting dopamine transport (DAT) inhibitor, PD2XXX, for the symptomatic treatment of Alzheimer's disease (AD). The core symptom of AD is short-term memory impairment. (DSM-IV) In preliminary studies, PD2XXX improved short term memory by over 110% in a well-accepted triple transgenic mouse model of AD (3xTg ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
A novel antisense therapeutic for treatment of Aspergillus fumigatus infections
SBC: GUILD ASSOCIATES INC Topic: NIAIDDESCRIPTION (provided by applicant): Guild proposes to develop an antisense oligomer-based antifungal effective against the human pathogen Aspergillus fumigatus. With a 40%-60% mortality rate, invasive aspergillosis (IA) due to A. fumigatus now surpasses invasive candidiasis as the most frequent fungal cause of death, especially amongst immunocompromised patients. Successful therapy for IA with cu ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Endotoxin Neutralization as a Biomonitor for HIV Disease Progression
SBC: BIODTECH, INC. Topic: NIAIDDESCRIPTION (provided by applicant): Endotoxin neutralization in human plasma is an excellent indicator of chronic immune activation, which is the most accurate predictor of mortality in HIV. Recently we developed an assay using endotoxin neutralization asan indicator of bacterial translocation. This assay is accurate in discriminating control patients from those with inflammatory bowel disease in ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Targeting the Core Binding Factor tumor suppressor in MLL-fusion AML
SBC: P2D, INC Topic: NCIDESCRIPTION (provided by applicant): RUNX1 is considered a beneficial tumor suppressor in myeloid neoplasms. Inhibition of RUNX1 function has been implicated as an important mechanistic event in the development of core-binding factor-(CBF)-leukemia and MLL-fusion leukemia. Inactivating RUNX1 mutations are frequently found in patients with acute myeloid leukemia (AML). However, RUNX1 mutation is us ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Fecal DNA Testing for Colorectal cancer Screening
SBC: GLC Biotechnology, Inc. Topic: NCIDESCRIPTION (provided by applicant): This is the Phase I application of a SBIR project that will be devoted to develop a new fecal DNA test for CRC screening, which will utilize a new tri-marker panel discovered in our preliminary study. CRC is the seconddeadliest cancer in USA. The good news is that early detection along with resection is associated with a five-year survival rate of nearly 100%. ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
New High Throughput Anti-Tumor Drug Screening System
SBC: Vivo Biosciences Inc Topic: NCIDESCRIPTION (provided by applicant): This SBIR project is focused to develop, validate and commercialize an advanced high-throughput anti- tumor drug screening platform (HTS) which employs a new 3D HuBioGEM assay technology. Preclinical drug screening is commonly performed using biochemical and cell-based assay systems. In recent years, more relevant 3D spheroid models have been developed using mi ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health